De novo biosynthesis of anticarcinogenic icariin in engineered yeast

Metab Eng. 2023 Nov:80:207-215. doi: 10.1016/j.ymben.2023.10.003. Epub 2023 Oct 16.

Abstract

Icariin (ICA) has wide applications in nutraceuticals and medicine with strong anticancer activities. However, the structural complexity and low abundance in plants of ICA lead to the unsustainable and high-cost supply from chemical synthesis and plant extraction. Here, the whole biosynthesis pathway of ICA was elucidated, then was constructed in Saccharomyces cerevisiae, including a 13-step heterologous ICA pathway from eleven kinds of plants as well as deletions or overexpression of ten yeast endogenous genes. Spatial regulation of 8-C-prenyltransferase to mitochondria and three-stage sequential control of 4'-O-methyltransferase, 3-OH rhamnosyltransferase, and 7-OH glycosyltransferase expression successfully achieved the de novo synthesis of ICA with a titer of 130 μg/L under shake-flask culture. The ICA synthesis from glucose represents the longest reconstructed pathway of flavonoid in microbe so far. This study provides a potential choice for the sustainable microbial production of number of complex flavonoids.

Keywords: Glycosylation; Icariin; Methylation; Prenylation; Saccharomyces cerevisiae; Temporospatial regulation.

MeSH terms

  • Flavonoids / genetics
  • Glucose / metabolism
  • Metabolic Engineering*
  • Saccharomyces cerevisiae* / genetics
  • Saccharomyces cerevisiae* / metabolism

Substances

  • icariin
  • Flavonoids
  • Glucose